Clear Harbor Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Clear Harbor Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-22,705	Closed	-$3.25M	–	281
2016 Q1	$3.25M	Sell	22,705 -580	-2%	-$82.4K	0.72%	34
2015 Q4	$3.6M	Buy	23,285 +30	+0.1%	+$4.38K	0.82%	30
2015 Q3	$3.32M	Buy	23,255 +4,330	+23%	+$605K	0.76%	33
2015 Q2	$2.72M	Buy	18,925 +7,258	+62%	+$1.04M	0.53%	43
2015 Q1	$1.65M	Sell	11,667 -481	-4%	-$74K	0.32%	72
2014 Q4	$1.8M	Buy	+12,148	New	+$1.78M	0.37%	66

Other funds holding TARO

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

Clear Harbor Asset Management's TARO Position: Q2 2016 in Review

Clear Harbor Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2016, closing a stake of 22,705 shares — an estimated $3.25M sold.

Clear Harbor Asset Management first reported a position in TARO in Q4 2014 and held it in 6 quarters. The position peaked at $3.6M in Q4 2015. 159 funds tracked by Wall St. Rank hold TARO as of Q2 2016.

Clear Harbor Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2016 after selling out during the quarter.
Clear Harbor Asset Management sold 22,705 Taro Pharmaceutical Industries Ltd. shares in Q2 2016, an estimated $3.25M.
Clear Harbor Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2014 and held it in 6 quarters.
Clear Harbor Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $3.6M in Q4 2015.
159 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2016.

Based on Clear Harbor Asset Management's 13F filing for Q2 2016, filed 5 Aug 2016.